Russia Pharmaceuticals Forecast Scenario

May 2006 | Industry Forecast

To reflect the optimistic consensus, BMI has significantly revised its forecasts for the Russian pharmaceutical market. The current estimated value of the market is calculated at US$7.7bn, compared to US$5.7bn previously. In addition growth rates have adjusted upwards. Market growth in local currency terms was around 15% per annum in 2003 and 2004, before jumping to an approximate 33% in 2005. BMI foresees that growth will continue at 11% to 12% over the forecast period. The rouble's current strong rate will boost market growth in US dollar terms in the near future, with expenditure set to reach US$12.9bn at consumer

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.